Top Clinical Trials companies in South Korea by Gross Profit Margin
South Korea
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
99.93%
|
Dec. 31, 2023 | USD 21.07 | 1.40% |
|
South Korea |
|
| 2 |
84.52%
|
Dec. 31, 2023 | USD 10.57 | -0.48% |
|
South Korea |
|
| 3 |
58.99%
|
Dec. 31, 2023 | USD 17.25 | 0.74% |
|
South Korea |
|
| 4 |
51.85%
|
Dec. 31, 2023 | USD 1.17 | -3.48% |
|
South Korea |
|
| 5 |
6.82%
|
Dec. 31, 2023 | USD 3.70 | 0.18% |
|
South Korea |
|
| 6 |
-37.27%
|
Dec. 31, 2023 | USD 1.67 | -1.86% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Gross Profit Margin ?
The Clinical Trials company in South Korea with the highest Gross Profit Margin is ABL Bio Inc. (KOSDAQ: 298380.KQ) at 99.93%.
-
Which Clinical Trials company in South Korea has the lowest Gross Profit Margin ?
The Clinical Trials company in South Korea with the lowest Gross Profit Margin is GeneOne Life Science, Inc. (KSE: 011000.KS) at -37.27%.
-
What are the top 10 Clinical Trials companies in South Korea by Gross Profit Margin ?
The top 10 Clinical Trials companies in South Korea by Gross Profit Margin are ABL Bio Inc., OliX Pharmaceuticals,Inc, Oscotec Inc., Gencurix Inc., Genexine, Inc. and GeneOne Life Science, Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Gross Profit Margin ?
The bottom 10 Clinical Trials companies in South Korea by Gross Profit Margin are GeneOne Life Science, Inc., Genexine, Inc., Gencurix Inc., Oscotec Inc., OliX Pharmaceuticals,Inc and ABL Bio Inc..